Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LENIOLISIB vs LENVATINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LENIOLISIB vs LENVATINIB: Safety Overview

Metric LENIOLISIB LENVATINIB
Total FAERS Reports 570 33,766
Deaths Reported 6 4,449
Death Rate 1.1% 13.2%
Hospitalizations 54 19,975
Average Patient Age 19.4 yrs 65.4 yrs
% Female Patients 27.3% 55.8%
FDA Approval Date Mar 24, 2023 Feb 13, 2015
Manufacturer Pharming Healthcare Inc. Eisai Inc.
Route ORAL ORAL
Marketing Status Prescription Prescription